Market Tracker

09/17 9:31am ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.45
Data as of Sep 16
 0.00 / 0.00%
Today’s Change
2.35
Today|||52-Week Range
5.30
-37.02%
Year-to-Date

Today’s Trading

Previous close2.45
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)373,141
Market cap$229.5M
Dividend yield--
Data as of 09/16/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc0.000.00%
NSTGNanoString Technolog...0.000.00%
ESPREsperion Therapeutic...0.000.00%
FPRXFive Prime Therapeut...0.000.00%
Data as of 09/16/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts